APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Pressurized Metered Dose Inhaler

A metered-dose inhaler (MDI) is a device that delivers a specific amount of medication to the lungs, in the form of a short burst of aerosolized medicine that is usually self-administered by the patient via inhalation. It is the most commonly used delivery system for treating asthma, chronic obstructive pulmonary disease (COPD) and other respiratory diseases. The medication in a metered dose inhaler is most commonly a bronchodilator, corticosteroid or a combination of both for the treatment of asthma and COPD. Other medications less commonly used but also administered by MDI are mast cell stabilizers, such as cromoglicate or nedocromil.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

A metered-dose inhaler (MDI) is a device that delivers a specific amount of medication to the lungs, in the form of a short burst of aerosolized medicine that is usually self-administered by the patient via inhalation. It is the most commonly used delivery system for treating asthma, chronic obstructive pulmonary disease (COPD) and other respiratory diseases. The medication in a metered dose inhaler is most commonly a bronchodilator, corticosteroid or a combination of both for the treatment of asthma and COPD. Other medications less commonly used but also administered by MDI are mast cell stabilizers, such as cromoglicate or nedocromil.

Selected research

Industry Growth & Trends

Global Pressurized Metered Dose Inhaler Industry Growth and Trends Forecast to 2032

Report ID 173920120128 December 202596 pages

Choose your research edition.

Industry ResearchPressurized Metered Dose Inhaler Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Pressurized Metered Dose Inhaler Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Pressurized Metered Dose Inhaler Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pressurized Metered Dose Inhaler Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Pressurized Metered Dose Inhaler Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

A metered-dose inhaler (MDI) is a device that delivers a specific amount of medication to the lungs, in the form of a short burst of aerosolized medicine that is usually self-administered by the patient via inhalation. It is the most commonly used delivery system for treating asthma, chronic obstructive pulmonary disease (COPD) and other respiratory diseases. The medication in a metered dose inhaler is most commonly a bronchodilator, corticosteroid or a combination of both for the treatment of asthma and COPD. Other medications less commonly used but also administered by MDI are mast cell stabilizers, such as cromoglicate or nedocromil.

The classification of Pressurized Metered Dose Inhaler includes manual type and smart type. The proportion of manual type in 2019 is about 99%. But the smart metered-dose inhaler will have a much higher growth rate in the future.

Pressurized Metered Dose Inhaler is widely used for Asthma, COPD and Others. The most proportion of Pressurized Metered Dose Inhaler used for Asthma, and the proportion in 2019 is about 48.94%.

Read the full market overview

North America is the largest market, with a market share nearly 44.49% in 2019. Following North America, Europe is the second largest sales place with the sales market share of 26.40%.

Market competition is intense. GlaxoSmithKline, Chiesi Farmaceutici S.p.A, AstraZeneca, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.

Report Scope

This report provides a structured, data-driven view of the global Pressurized Metered Dose Inhaler market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Pressurized Metered Dose Inhaler market size, estimates, and forecasts are presented in terms of sales volume (M Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pressurized Metered Dose Inhaler market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pressurized Metered Dose Inhaler.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Pressurized Metered Dose Inhaler market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Pressurized Metered Dose Inhaler Market by Company

GlaxoSmithKline

Chiesi Farmaceutici S.p.A

AstraZeneca

Teva

Merck & Co. Inc

Boehringer Ingelheim

Mylan

Arkon

Pressurized Metered Dose Inhaler Segment by Type

Manual Pressurized Metered Dose Inhaler

Smart Pressurized Metered Dose Inhaler

Pressurized Metered Dose Inhaler Segment by Application

Asthma

COPD

Others

Pressurized Metered Dose Inhaler Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pressurized Metered Dose Inhaler market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pressurized Metered Dose Inhaler and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pressurized Metered Dose Inhaler.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pressurized Metered Dose Inhaler manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Pressurized Metered Dose Inhaler in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Manual Pressurized Metered Dose Inhaler Table 2. Major Company of Smart Pressurized Metered Dose Inhaler Table 3. Global Pressurized Metered Dose Inhaler Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Pressurized Metered Dose Inhaler Sales by Type (2021-2026) & (M Units) Table 5. Global Pressurized Metered Dose Inhaler Sales Market Share in Volume by Type (2021-2026) Table 6. Global Pressurized Metered Dose Inhaler Sales by Type (2021-2026) & (US$ Million) Table 7. Global Pressurized Metered Dose Inhaler Sales Market Share in Value by Type (2021-2026) Table 8. Global Pressurized Metered Dose Inhaler Price by Type (2021-2026) & (US$/Unit) Table 9. Global Pressurized Metered Dose Inhaler Sales by Type (2027-2032) & (M Units) Table 10. Global Pressurized Metered Dose Inhaler Sales Market Share in Volume by Type (2027-2032) Table 11. Global Pressurized Metered Dose Inhaler Sales by Type (2027-2032) & (US$ Million) Table 12. Global Pressurized Metered Dose Inhaler Sales Market Share in Value by Type (2027-2032) Table 13. Global Pressurized Metered Dose Inhaler Price by Type (2027-2032) & (US$/Unit) Table 14. North America Pressurized Metered Dose Inhaler Sales by Type (2021-2026) & (M Units) Table 15. North America Pressurized Metered Dose Inhaler Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Pressurized Metered Dose Inhaler Sales by Type (2021-2026) & (M Units) Table 17. Europe Pressurized Metered Dose Inhaler Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Pressurized Metered Dose Inhaler Sales by Type (2021-2026) & (M Units) Table 19. Asia-Pacific Pressurized Metered Dose Inhaler Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Pressurized Metered Dose Inhaler Sales by Type (2021-2026) & (M Units) Table 21. Latin America Pressurized Metered Dose Inhaler Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Pressurized Metered Dose Inhaler Sales by Type (2021-2026) & (M Units) Table 23. Middle East and Africa Pressurized Metered Dose Inhaler Sales by Type (2021-2026) & (US$ Million) Table 24. Pressurized Metered Dose Inhaler Industry Trends Table 25. Pressurized Metered Dose Inhaler Industry Drivers Table 26. Pressurized Metered Dose Inhaler Industry Opportunities and Challenges Table 27. Pressurized Metered Dose Inhaler Industry Restraints Table 28. Global Pressurized Metered Dose Inhaler Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Pressurized Metered Dose Inhaler Revenue Market Share by Company (2021-2026) Table 30. Global Pressurized Metered Dose Inhaler Sales by Company (2021-2026) & (M Units) Table 31. Global Pressurized Metered Dose Inhaler Sales Share by Company (2021-2026) Table 32. Global Pressurized Metered Dose Inhaler Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Pressurized Metered Dose Inhaler Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Pressurized Metered Dose Inhaler Major Company Production Sites and Headquarters Table 35. Global Pressurized Metered Dose Inhaler Company, Product Type & Application Table 36. Global Pressurized Metered Dose Inhaler Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Pressurized Metered Dose Inhaler by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Pressurized Metered Dose Inhaler Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Pressurized Metered Dose Inhaler Sales by Region (2021-2026) & (M Units) Table 41. Global Pressurized Metered Dose Inhaler Sales Market Share in Volume by Region (2021-2026) Table 42. Global Pressurized Metered Dose Inhaler Sales by Region (2021-2026) & (US$ Million) Table 43. Global Pressurized Metered Dose Inhaler Sales Market Share in Value by Region (2021-2026) Table 44. Global Pressurized Metered Dose Inhaler Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Pressurized Metered Dose Inhaler Sales by Region (2027-2032) & (M Units) Table 46. Global Pressurized Metered Dose Inhaler Sales Market Share in Volume by Region (2027-2032) Table 47. Global Pressurized Metered Dose Inhaler Sales by Region (2027-2032) & (US$ Million) Table 48. Global Pressurized Metered Dose Inhaler Sales Market Share in Value by Region (2027-2032) Table 49. Global Pressurized Metered Dose Inhaler Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Pressurized Metered Dose Inhaler Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Pressurized Metered Dose Inhaler Sales by Application (2021-2026) & (M Units) Table 52. Global Pressurized Metered Dose Inhaler Sales Market Share in Volume by Application (2021-2026) Table 53. Global Pressurized Metered Dose Inhaler Sales by Application (2021-2026) & (US$ Million) Table 54. Global Pressurized Metered Dose Inhaler Sales Market Share in Value by Application (2021-2026) Table 55. Global Pressurized Metered Dose Inhaler Price by Application (2021-2026) & (US$/Unit) Table 56. Global Pressurized Metered Dose Inhaler Sales by Application (2027-2032) & (M Units) Table 57. Global Pressurized Metered Dose Inhaler Sales Market Share in Volume by Application (2027-2032) Table 58. Global Pressurized Metered Dose Inhaler Sales by Application (2027-2032) & (US$ Million) Table 59. Global Pressurized Metered Dose Inhaler Sales Market Share in Value by Application (2027-2032) Table 60. Global Pressurized Metered Dose Inhaler Price by Application (2027-2032) & (US$/Unit) Table 61. North America Pressurized Metered Dose Inhaler Sales by Application (2021-2026) & (M Units) Table 62. North America Pressurized Metered Dose Inhaler Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Pressurized Metered Dose Inhaler Sales by Application (2021-2026) & (M Units) Table 64. Europe Pressurized Metered Dose Inhaler Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Pressurized Metered Dose Inhaler Sales by Application (2021-2026) & (M Units) Table 66. Asia-Pacific Pressurized Metered Dose Inhaler Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Pressurized Metered Dose Inhaler Sales by Application (2021-2026) & (M Units) Table 68. Latin America Pressurized Metered Dose Inhaler Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Pressurized Metered Dose Inhaler Sales by Application (2021-2026) & (M Units) Table 70. Middle East and Africa Pressurized Metered Dose Inhaler Sales by Application (2021-2026) & (US$ Million) Table 71. GlaxoSmithKline Company Information Table 72. GlaxoSmithKline Business Overview Table 73. GlaxoSmithKline Pressurized Metered Dose Inhaler Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. GlaxoSmithKline Pressurized Metered Dose Inhaler Product Portfolio Table 75. GlaxoSmithKline Recent Development Table 76. Chiesi Farmaceutici S.p.A Company Information Table 77. Chiesi Farmaceutici S.p.A Business Overview Table 78. Chiesi Farmaceutici S.p.A Pressurized Metered Dose Inhaler Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Chiesi Farmaceutici S.p.A Pressurized Metered Dose Inhaler Product Portfolio Table 80. Chiesi Farmaceutici S.p.A Recent Development Table 81. AstraZeneca Company Information Table 82. AstraZeneca Business Overview Table 83. AstraZeneca Pressurized Metered Dose Inhaler Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. AstraZeneca Pressurized Metered Dose Inhaler Product Portfolio Table 85. AstraZeneca Recent Development Table 86. Teva Company Information Table 87. Teva Business Overview Table 88. Teva Pressurized Metered Dose Inhaler Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Teva Pressurized Metered Dose Inhaler Product Portfolio Table 90. Teva Recent Development Table 91. Merck & Co. Inc Company Information Table 92. Merck & Co. Inc Business Overview Table 93. Merck & Co. Inc Pressurized Metered Dose Inhaler Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Merck & Co. Inc Pressurized Metered Dose Inhaler Product Portfolio Table 95. Merck & Co. Inc Recent Development Table 96. Boehringer Ingelheim Company Information Table 97. Boehringer Ingelheim Business Overview Table 98. Boehringer Ingelheim Pressurized Metered Dose Inhaler Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Boehringer Ingelheim Pressurized Metered Dose Inhaler Product Portfolio Table 100. Boehringer Ingelheim Recent Development Table 101. Mylan Company Information Table 102. Mylan Business Overview Table 103. Mylan Pressurized Metered Dose Inhaler Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Mylan Pressurized Metered Dose Inhaler Product Portfolio Table 105. Mylan Recent Development Table 106. Arkon Company Information Table 107. Arkon Business Overview Table 108. Arkon Pressurized Metered Dose Inhaler Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Arkon Pressurized Metered Dose Inhaler Product Portfolio Table 110. Arkon Recent Development Table 111. North America Pressurized Metered Dose Inhaler Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 112. North America Pressurized Metered Dose Inhaler Sales by Country (2021-2026) & (M Units) Table 113. North America Pressurized Metered Dose Inhaler Sales Market Share by Country (2021-2026) Table 114. North America Pressurized Metered Dose Inhaler Sales Forecast by Country (2027-2032) & (M Units) Table 115. North America Pressurized Metered Dose Inhaler Sales Market Share Forecast by Country (2027-2032) Table 116. North America Pressurized Metered Dose Inhaler Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. North America Pressurized Metered Dose Inhaler Market Size by Country (2021-2026) & (US$ Million) Table 118. North America Pressurized Metered Dose Inhaler Market Share by Country (2021-2026) Table 119. North America Pressurized Metered Dose Inhaler Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. North America Pressurized Metered Dose Inhaler Market Share Forecast by Country (2027-2032) Table 121. Europe Pressurized Metered Dose Inhaler Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 122. Europe Pressurized Metered Dose Inhaler Sales by Country (2021-2026) & (M Units) Table 123. Europe Pressurized Metered Dose Inhaler Sales Market Share by Country (2021-2026) Table 124. Europe Pressurized Metered Dose Inhaler Sales Forecast by Country (2027-2032) & (M Units) Table 125. Europe Pressurized Metered Dose Inhaler Sales Market Share Forecast by Country (2027-2032) Table 126. Europe Pressurized Metered Dose Inhaler Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Europe Pressurized Metered Dose Inhaler Market Size by Country (2021-2026) & (US$ Million) Table 128. Europe Pressurized Metered Dose Inhaler Market Share by Country (2021-2026) Table 129. Europe Pressurized Metered Dose Inhaler Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Europe Pressurized Metered Dose Inhaler Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Pressurized Metered Dose Inhaler Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Pressurized Metered Dose Inhaler Sales by Country (2021-2026) & (M Units) Table 133. Asia-Pacific Pressurized Metered Dose Inhaler Sales Market Share by Country (2021-2026) Table 134. Asia-Pacific Pressurized Metered Dose Inhaler Sales Forecast by Country (2027-2032) & (M Units) Table 135. Asia-Pacific Pressurized Metered Dose Inhaler Sales Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Pressurized Metered Dose Inhaler Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Pressurized Metered Dose Inhaler Market Size by Country (2021-2026) & (US$ Million) Table 138. Asia-Pacific Pressurized Metered Dose Inhaler Market Share by Country (2021-2026) Table 139. Asia-Pacific Pressurized Metered Dose Inhaler Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Asia-Pacific Pressurized Metered Dose Inhaler Market Share Forecast by Country (2027-2032) Table 141. Latin America Pressurized Metered Dose Inhaler Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 142. Latin America Pressurized Metered Dose Inhaler Sales by Country (2021-2026) & (M Units) Table 143. Latin America Pressurized Metered Dose Inhaler Sales Market Share by Country (2021-2026) Table 144. Latin America Pressurized Metered Dose Inhaler Sales Forecast by Country (2027-2032) & (M Units) Table 145. Latin America Pressurized Metered Dose Inhaler Sales Market Share Forecast by Country (2027-2032) Table 146. Latin America Pressurized Metered Dose Inhaler Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Latin America Pressurized Metered Dose Inhaler Market Size by Country (2021-2026) & (US$ Million) Table 148. Latin America Pressurized Metered Dose Inhaler Market Share by Country (2021-2026) Table 149. Latin America Pressurized Metered Dose Inhaler Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Latin America Pressurized Metered Dose Inhaler Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Pressurized Metered Dose Inhaler Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Pressurized Metered Dose Inhaler Sales by Country (2021-2026) & (M Units) Table 153. Middle East and Africa Pressurized Metered Dose Inhaler Sales Market Share by Country (2021-2026) Table 154. Middle East and Africa Pressurized Metered Dose Inhaler Sales Forecast by Country (2027-2032) & (M Units) Table 155. Middle East and Africa Pressurized Metered Dose Inhaler Sales Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Pressurized Metered Dose Inhaler Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Pressurized Metered Dose Inhaler Market Size by Country (2021-2026) & (US$ Million) Table 158. Middle East and Africa Pressurized Metered Dose Inhaler Market Share by Country (2021-2026) Table 159. Middle East and Africa Pressurized Metered Dose Inhaler Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Middle East and Africa Pressurized Metered Dose Inhaler Market Share Forecast by Country (2027-2032) Table 161. Key Raw Materials Table 162. Raw Materials Key Suppliers Table 163. Pressurized Metered Dose Inhaler Distributors List Table 164. Pressurized Metered Dose Inhaler Customers List Table 165. Research Programs/Design for This Report Table 166. Authors List of This Report Table 167. Secondary Sources Table 168. Primary Sources List of Figures Figure 1. Pressurized Metered Dose Inhaler Image Figure 2. Global Pressurized Metered Dose Inhaler Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pressurized Metered Dose Inhaler Market Size (2021-2032) & (US$ Million) Figure 4. Global Pressurized Metered Dose Inhaler Sales (2021-2032) & (M Units) Figure 5. Manual Pressurized Metered Dose Inhaler Image Figure 6. Global Manual Pressurized Metered Dose Inhaler Sales YoY Growth (2021-2032) & (M Units) Figure 7. Smart Pressurized Metered Dose Inhaler Image Figure 8. Global Smart Pressurized Metered Dose Inhaler Sales YoY Growth (2021-2032) & (M Units) Figure 9. Global Pressurized Metered Dose Inhaler Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Pressurized Metered Dose Inhaler Market Share by Type 2025 VS 2032 Figure 11. North America Pressurized Metered Dose Inhaler Sales Market Share in Volume by Type in 2025 Figure 12. North America Pressurized Metered Dose Inhaler Sales Market Share in Value by Type in 2025 Figure 13. Europe Pressurized Metered Dose Inhaler Sales Market Share in Volume by Type in 2025 Figure 14. Europe Pressurized Metered Dose Inhaler Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Pressurized Metered Dose Inhaler Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Pressurized Metered Dose Inhaler Sales Market Share in Value by Type in 2025 Figure 17. Latin America Pressurized Metered Dose Inhaler Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Pressurized Metered Dose Inhaler Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Pressurized Metered Dose Inhaler Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Pressurized Metered Dose Inhaler Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Pressurized Metered Dose Inhaler Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Asthma Image Figure 24. Global Asthma Sales YoY Growth (2021-2032) & (M Units) Figure 25. COPD Image Figure 26. Global COPD Sales YoY Growth (2021-2032) & (M Units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (M Units) Figure 29. Global Pressurized Metered Dose Inhaler Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Pressurized Metered Dose Inhaler Market Share by Application 2025 VS 2032 Figure 31. North America Pressurized Metered Dose Inhaler Sales Market Share in Volume by Application in 2025 Figure 32. North America Pressurized Metered Dose Inhaler Sales Market Share in Value by Application in 2025 Figure 33. Europe Pressurized Metered Dose Inhaler Sales Market Share in Volume by Application in 2025 Figure 34. Europe Pressurized Metered Dose Inhaler Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Pressurized Metered Dose Inhaler Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Pressurized Metered Dose Inhaler Sales Market Share in Value by Application in 2025 Figure 37. Latin America Pressurized Metered Dose Inhaler Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Pressurized Metered Dose Inhaler Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Pressurized Metered Dose Inhaler Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Pressurized Metered Dose Inhaler Sales Market Share in Value by Application in 2025 Figure 41. North America Pressurized Metered Dose Inhaler Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 42. North America Pressurized Metered Dose Inhaler Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Pressurized Metered Dose Inhaler Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Pressurized Metered Dose Inhaler Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Pressurized Metered Dose Inhaler Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 46. Europe Pressurized Metered Dose Inhaler Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Pressurized Metered Dose Inhaler Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Pressurized Metered Dose Inhaler Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Pressurized Metered Dose Inhaler Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 50. Asia-Pacific Pressurized Metered Dose Inhaler Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Pressurized Metered Dose Inhaler Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Pressurized Metered Dose Inhaler Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Pressurized Metered Dose Inhaler Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 54. Latin America Pressurized Metered Dose Inhaler Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Pressurized Metered Dose Inhaler Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Pressurized Metered Dose Inhaler Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Pressurized Metered Dose Inhaler Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 58. Middle East and Africa Pressurized Metered Dose Inhaler Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Pressurized Metered Dose Inhaler Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Pressurized Metered Dose Inhaler Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Pressurized Metered Dose Inhaler Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Pressurized Metered Dose Inhaler Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Manual Pressurized Metered Dose Inhaler
  • Smart Pressurized Metered Dose Inhaler
Applications
  • Asthma
  • COPD
  • Others
Companies covered
  • GlaxoSmithKline
  • Chiesi Farmaceutici S.p.A
  • AstraZeneca
  • Teva
  • Merck & Co. Inc
  • Boehringer Ingelheim
  • Mylan
  • Arkon

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pressurized Metered Dose Inhaler Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Pressurized Metered Dose Inhaler Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Pressurized Metered Dose Inhaler Market by Type
  6. 1.3.1 Manual Pressurized Metered Dose Inhaler
  7. 1.3.2 Smart Pressurized Metered Dose Inhaler
  8. 1.4 Global Pressurized Metered Dose Inhaler Market Size by Type
  9. 1.4.1 Global Pressurized Metered Dose Inhaler Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Pressurized Metered Dose Inhaler Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Pressurized Metered Dose Inhaler Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Pressurized Metered Dose Inhaler Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Pressurized Metered Dose Inhaler Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Pressurized Metered Dose Inhaler Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Pressurized Metered Dose Inhaler Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Pressurized Metered Dose Inhaler Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Pressurized Metered Dose Inhaler Industry Trends
  2. 2.2 Pressurized Metered Dose Inhaler Industry Drivers
  3. 2.3 Pressurized Metered Dose Inhaler Industry Opportunities and Challenges
  4. 2.4 Pressurized Metered Dose Inhaler Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Pressurized Metered Dose Inhaler Revenue (2021-2026)
  2. 3.2 Global Top Players by Pressurized Metered Dose Inhaler Sales (2021-2026)
  3. 3.3 Global Top Players by Pressurized Metered Dose Inhaler Price (2021-2026)
  4. 3.4 Global Pressurized Metered Dose Inhaler Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pressurized Metered Dose Inhaler Major Company Production Sites & Headquarters
  6. 3.6 Global Pressurized Metered Dose Inhaler Company, Product Type & Application
  7. 3.7 Global Pressurized Metered Dose Inhaler Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pressurized Metered Dose Inhaler Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pressurized Metered Dose Inhaler Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pressurized Metered Dose Inhaler Tier 1, Tier 2, and Tier 3
4 Pressurized Metered Dose Inhaler Regional Status and Outlook
  1. 4.1 Global Pressurized Metered Dose Inhaler Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Pressurized Metered Dose Inhaler Historic Market Size by Region
  3. 4.2.1 Global Pressurized Metered Dose Inhaler Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Pressurized Metered Dose Inhaler Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Pressurized Metered Dose Inhaler Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Pressurized Metered Dose Inhaler Forecasted Market Size by Region
  7. 4.3.1 Global Pressurized Metered Dose Inhaler Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Pressurized Metered Dose Inhaler Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Pressurized Metered Dose Inhaler Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Pressurized Metered Dose Inhaler by Application
  1. 5.1 Pressurized Metered Dose Inhaler Market by Application
  2. 5.1.1 Asthma
  3. 5.1.2 COPD
  4. 5.1.3 Others
  5. 5.2 Global Pressurized Metered Dose Inhaler Market Size by Application
  6. 5.2.1 Global Pressurized Metered Dose Inhaler Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Pressurized Metered Dose Inhaler Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Pressurized Metered Dose Inhaler Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Pressurized Metered Dose Inhaler Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Pressurized Metered Dose Inhaler Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Pressurized Metered Dose Inhaler Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Pressurized Metered Dose Inhaler Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Pressurized Metered Dose Inhaler Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 GlaxoSmithKline
  2. 6.1.1 GlaxoSmithKline Company Information
  3. 6.1.2 GlaxoSmithKline Business Overview
  4. 6.1.3 GlaxoSmithKline Pressurized Metered Dose Inhaler Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 GlaxoSmithKline Pressurized Metered Dose Inhaler Product Portfolio
  6. 6.1.5 GlaxoSmithKline Recent Developments
  7. 6.2 Chiesi Farmaceutici S.p.A
  8. 6.2.1 Chiesi Farmaceutici S.p.A Company Information
  9. 6.2.2 Chiesi Farmaceutici S.p.A Business Overview
  10. 6.2.3 Chiesi Farmaceutici S.p.A Pressurized Metered Dose Inhaler Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Chiesi Farmaceutici S.p.A Pressurized Metered Dose Inhaler Product Portfolio
  12. 6.2.5 Chiesi Farmaceutici S.p.A Recent Developments
  13. 6.3 AstraZeneca
  14. 6.3.1 AstraZeneca Company Information
  15. 6.3.2 AstraZeneca Business Overview
  16. 6.3.3 AstraZeneca Pressurized Metered Dose Inhaler Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 AstraZeneca Pressurized Metered Dose Inhaler Product Portfolio
  18. 6.3.5 AstraZeneca Recent Developments
  19. 6.4 Teva
  20. 6.4.1 Teva Company Information
  21. 6.4.2 Teva Business Overview
  22. 6.4.3 Teva Pressurized Metered Dose Inhaler Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Teva Pressurized Metered Dose Inhaler Product Portfolio
  24. 6.4.5 Teva Recent Developments
  25. 6.5 Merck & Co. Inc
  26. 6.5.1 Merck & Co. Inc Company Information
  27. 6.5.2 Merck & Co. Inc Business Overview
  28. 6.5.3 Merck & Co. Inc Pressurized Metered Dose Inhaler Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Merck & Co. Inc Pressurized Metered Dose Inhaler Product Portfolio
  30. 6.5.5 Merck & Co. Inc Recent Developments
  31. 6.6 Boehringer Ingelheim
  32. 6.6.1 Boehringer Ingelheim Company Information
  33. 6.6.2 Boehringer Ingelheim Business Overview
  34. 6.6.3 Boehringer Ingelheim Pressurized Metered Dose Inhaler Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Boehringer Ingelheim Pressurized Metered Dose Inhaler Product Portfolio
  36. 6.6.5 Boehringer Ingelheim Recent Developments
  37. 6.7 Mylan
  38. 6.7.1 Mylan Company Information
  39. 6.7.2 Mylan Business Overview
  40. 6.7.3 Mylan Pressurized Metered Dose Inhaler Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Mylan Pressurized Metered Dose Inhaler Product Portfolio
  42. 6.7.5 Mylan Recent Developments
  43. 6.8 Arkon
  44. 6.8.1 Arkon Company Information
  45. 6.8.2 Arkon Business Overview
  46. 6.8.3 Arkon Pressurized Metered Dose Inhaler Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Arkon Pressurized Metered Dose Inhaler Product Portfolio
  48. 6.8.5 Arkon Recent Developments
7 North America by Country
  1. 7.1 North America Pressurized Metered Dose Inhaler Sales by Country
  2. 7.1.1 North America Pressurized Metered Dose Inhaler Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Pressurized Metered Dose Inhaler Sales by Country (2021-2026)
  4. 7.1.3 North America Pressurized Metered Dose Inhaler Sales Forecast by Country (2027-2032)
  5. 7.2 North America Pressurized Metered Dose Inhaler Market Size by Country
  6. 7.2.1 North America Pressurized Metered Dose Inhaler Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Pressurized Metered Dose Inhaler Market Size by Country (2021-2026)
  8. 7.2.3 North America Pressurized Metered Dose Inhaler Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Pressurized Metered Dose Inhaler Sales by Country
  2. 8.1.1 Europe Pressurized Metered Dose Inhaler Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Pressurized Metered Dose Inhaler Sales by Country (2021-2026)
  4. 8.1.3 Europe Pressurized Metered Dose Inhaler Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Pressurized Metered Dose Inhaler Market Size by Country
  6. 8.2.1 Europe Pressurized Metered Dose Inhaler Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Pressurized Metered Dose Inhaler Market Size by Country (2021-2026)
  8. 8.2.3 Europe Pressurized Metered Dose Inhaler Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Pressurized Metered Dose Inhaler Sales by Country
  2. 9.1.1 Asia-Pacific Pressurized Metered Dose Inhaler Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Pressurized Metered Dose Inhaler Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Pressurized Metered Dose Inhaler Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Pressurized Metered Dose Inhaler Market Size by Country
  6. 9.2.1 Asia-Pacific Pressurized Metered Dose Inhaler Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Pressurized Metered Dose Inhaler Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Pressurized Metered Dose Inhaler Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Pressurized Metered Dose Inhaler Sales by Country
  2. 10.1.1 South America Pressurized Metered Dose Inhaler Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Pressurized Metered Dose Inhaler Sales by Country (2021-2026)
  4. 10.1.3 South America Pressurized Metered Dose Inhaler Sales Forecast by Country (2027-2032)
  5. 10.2 South America Pressurized Metered Dose Inhaler Market Size by Country
  6. 10.2.1 South America Pressurized Metered Dose Inhaler Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Pressurized Metered Dose Inhaler Market Size by Country (2021-2026)
  8. 10.2.3 South America Pressurized Metered Dose Inhaler Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Pressurized Metered Dose Inhaler Sales by Country
  2. 11.1.1 Middle East and Africa Pressurized Metered Dose Inhaler Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Pressurized Metered Dose Inhaler Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Pressurized Metered Dose Inhaler Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Pressurized Metered Dose Inhaler Market Size by Country
  6. 11.2.1 Middle East and Africa Pressurized Metered Dose Inhaler Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Pressurized Metered Dose Inhaler Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Pressurized Metered Dose Inhaler Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Pressurized Metered Dose Inhaler Value Chain Analysis
  2. 12.1.1 Pressurized Metered Dose Inhaler Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Pressurized Metered Dose Inhaler Production Mode & Process
  7. 12.2 Pressurized Metered Dose Inhaler Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Pressurized Metered Dose Inhaler Distributors
  10. 12.2.3 Pressurized Metered Dose Inhaler Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst